Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients

por Hohl Moinat, Christine, Périard, Daniel, Grueber, Adrienne, Hayoz, Daniel, Magnin, Jean-Luc, André, Pascal, Kung, Marc, Betticher, Daniel C.
Publicado 2014

Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment

por Menges, Dominik, Piatti, Michela C., Omlin, Aurelius, Cathomas, Richard, Benamran, Daniel, Fischer, Stefanie, Iselin, Christophe, Küng, Marc, Lorch, Anja, Prause, Lukas, Rothermundt, Christian, O'Meara Stern, Alix, Zihler, Deborah, Lippuner, Max, Braun, Julia, Cerny, Thomas, Puhan, Milo A.
Publicado 2023

High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup ph...

por Fehr, Martin, Hawle, Hanne, Hayoz, Stefanie, Thuss-Patience, Peter, Schacher, Sabina, Riera Knorrenschild, Jorge, Dürr, Donat, Knoefel, Wolfram T., Rumpold, Holger, Bitzer, Michael, Zweifel, Martin, Samaras, Panagiotis, Mey, Ulrich, Küng, Marc, Winterhalder, Ralph, Eisterer, Wolfgang, Hess, Viviane, Gérard, Marie-Aline, Templeton, Arnoud, Stahl, Michael, Ruhstaller, Thomas
Publicado 2020

SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-neg...

por Rochlitz, Christoph, Bigler, Martin, von Moos, Roger, Bernhard, Jürg, Matter-Walstra, Klazien, Wicki, Andreas, Zaman, Khalil, Anchisi, Sandro, Küng, Marc, Na, Kyung-Jae, Bärtschi, Daniela, Borner, Markus, Rordorf, Tamara, Rauch, Daniel, Müller, Andreas, Ruhstaller, Thomas, Vetter, Marcus, Trojan, Andreas, Hasler-Strub, Ursula, Cathomas, Richard, Winterhalder, Ralph
Publicado 2016